Leash Biosciences
San Francisco, United States· Est. 2020
We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.
Private Company
Total funding raised: $4M
About
We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.
CRISPRGene Therapy
Funding History
1Total raised:$4M
Seed$4MMay 15, 2023